Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry and FDA Staff; Compliance with Section 301 of the Medical Device User Fee and Modernization Act of 2002, as Amended: Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices (formerly “Reprocessed Single-Use Device Labeling”)

1 organizations filed 1 public comment on Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry and FDA Staff; Compliance with Section 301 of the Medical Device User Fee and Modernization Act of 2002, as Amended: Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices (formerly “Reprocessed Single-Use Device Labeling”), at the Food and Drug Administration. The comment window closed 6402d ago.

Commenters (1)

• Advanced Medical Technology Associationtrade assoc.

  1 filing · confidence 97%